Daniel Wetterskog PhD

Dr Daniel Wetterskog is the Senior Scientific Officer in the Treatment Resistance team at the Institute of Cancer Research in Sutton, UK. In his position Daniel is in charge of project supervision and implementation and development of methods for interrogation of clinical samples with a focus on cell free DNA found in plasma.

Daniel completed his Ph.D. in 2008, working on transcriptional dysregulation in cancer at the University of Gothenburg, Sweden. After a post-doctoral position at the Institute of Cancer Research London focusing on identification of resistance mechanisms to HER2 targeting agents and a second post-doctoral position at University College London Cancer Institute focusing on radiosensitization of cancers he re-joined the Institute of Cancer Research in 2014 to continue his work on understanding and overcoming treatment resistances in cancer.